Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety profile of liquid deferiprone (GPO-L-ONE) in thalassemia children with transfusion-induced iron overload
TCTR20170907001Phase 3Recruiting
- Sponsor
- N/A
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of deferiprone in Thalassaemia, Transfusional Siderosis, sponsored by N/A. Started Aug 2017; status: recruiting.
02
Drugs
deferiprone
03
Conditions
ThalassaemiaTransfusional Siderosis
Beyond the preview
Go deeper on TCTR20170907001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170907001.